Atopic dermatitis (AD) is a multifactorial allergic infl ammatory skin disorder characterized by pruritic and eczematoid skin lesions. AD is commonly present in early infancy and childhood, although it can occur later in life and persist into adulthood (Barker et al., 2007;Brenninkmeijer et al., 2009). It results from interactions between susceptibility genes, the host's environment, skin barrier defects, bacterial and viral skin infections, and immunological factors (Leung and Bieber, 2003). Recent immunological analyses of the pathogenesis of AD have revealed that activated mast cells and an excess in the number of differentiated T-helper 2 (Th2) cells (caused by chemical mediators and cytokines) may play major roles in the development of dermatitis by elevating serum immunoglobulin E (IgE) levels (Leung, 1995). They may trigger the massive infi ltration of T cells, eosinophils, mast cells, and macrophages that characterizes AD (Alenius et al., 2002;Milgrom, 2002;Chen et al., 2005).We examined the effects of essential oil from Thujopsis dolobrata Sieb. et Zucc. var. hondai Makino (EOTD) (Cupressaceae) on atopic dermatitis (AD)-like skin lesions in NC/Nga mice. Treatment with EOTD twice daily for two weeks ameliorate AD-like skin lesions induced by DNCB (2,4 dinitrochlorobenzene), and clinical scores were reduced to 7.29, 7.07, and 4.5 points in the groups treated with 1.5%, 3.0%, and 6.0% extract (p<0.01) respectively, from the 15.0 score obtained using vehicle. EOTD inhibited the infi ltration of mast cells into the AD-like skin lesion in NC/Nga mice (p<0.01) and also reduced serum histamine and IgE levels (p<0.05). Furthermore, it dose-dependently inhibited the release of beta-hexosaminidase from rat basophilic leukemia RBL 2H3 cells. These results indicate that EOTD reduces AD-like skin lesions by inhibiting the production of IgE and histamine, and, thus, IgE-mediated degranulation.